ICER plots ear­ly sci­en­tif­ic ad­vice pro­gram for bio­phar­ma

The In­sti­tute for Clin­i­cal and Eco­nom­ic Re­view (ICER) is look­ing to help the bio­phar­ma in­dus­try with ear­li­er re­views of clin­i­cal work, adding to their cur­rent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.